UBS plans to price airbag phoenix autocallables linked to Regeneron

By Angela McDaniels

Tacoma, Wash., Nov. 5 – UBS AG, London Branch plans to price airbag phoenix autocallable optimization securities due May 13, 2016 linked to the common stock of Regeneron Pharmaceuticals, Inc., according to an FWP filing with the Securities and Exchange Commission.

Each month, the notes will pay a contingent coupon at the rate of 8.35% to 10.35% per year if Regeneron shares close at or above the coupon barrier, 70% of the initial share price, on the observation date for that month.

The notes will be automatically called at par if Regeneron shares close at or above the initial share price on any autocall observation date, which occur quarterly.

If the notes are not called and the final price of Regeneron shares is greater than or equal to the conversion price, 85% of the initial share price, the payout at maturity will be par. Otherwise, investors will receive a number of Regeneron shares equal to $1,000 divided by the conversion price.

UBS Financial Services Inc. and UBS Investment Bank are the agents.

The notes are expected to price Nov. 7 and settle Nov. 13.

The Cusip number is 90274B873.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.